Human Gene Editing and Bioethics Boundaries
Public trust in healthcare communication and bioethical boundaries surrounding human genetic enhancement.
0 sourcesVoices in this topic
All paragraphs
Oct 6, 2026
- Andrew Huberman The health-optimization media market is approaching a credibility reset after attention incentives pushed educators toward theatrical escalation. Huberman calls the discourse “a fucking disaster,” argues that “it’s very easy to get attention” but “very hard to keep respect,” and …
- Huberman argues that genetic enhancement is no longer a hypothetical governance problem, but carefully separates established events from speculation. He points to He Jiankui’s CRISPR-edited twins, embryo screening, and follistatin gene-therapy efforts as evidence that human genetic-control …
